Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China

Abstract Background Pyrazinamide still may be a useful drug for treatment of rifampin-resistant (RR-TB) or multidrug-resistant tuberculosis (MDR-TB) in China while awaiting scale up of new drugs and regimens including bedaquiline and linezolid. The level of pyrazinamide resistance among MDR-TB patie...

全面介紹

書目詳細資料

Principais autores:	Hui Xia, Susan van den Hof, Frank Cobelens, Yang Zhou, Bing Zhao, Shengfen Wang, Yanlin Zhao
格式:	Artigo
語言:	Inglês
出版:	BMC 2020-01-01
叢編:	BMC Infectious Diseases
主題:	Multidrug-resistant tuberculosis Pyrazinamide Resistance pncA
在線閱讀:	https://doi.org/10.1186/s12879-020-4758-9
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!